ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
CIP Web Site: http://www.cancer.gov/bip
HiRES 2001 Meeting: URL: http://www.ornl.gov/HiRes2001/
- INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY MEETING - July 19, 2001
Due Date for Requests: June 7, 2001
The National Cancer Institute (NCI), Food and Drug Administration (FDA), and the Health Care Financing Administration (HCFA) are pleased to announce that the fourth meeting of the Interagency Council on Biomedical Imaging in Oncology will take place on Thursday, July 19, 2001. The Interagency Council is a newly created multi-agency group designed to serve as a sounding board for investigators and manufacturers attempting to take emerging medical imaging technology to market. It consists of a core staff from the FDA, HCFA, and NCI with experience and knowledge concerning the decision-making processes for their agency for medical imaging products. Requests to meet with the Interagency Council are initiated by the technology developers.
- NIMH RESEARCH CAREER AWARD FOR TRANSITION TO INDEPENDENCE (NIMH) (PAR-01-065)
Letter of Intent Receipt Date: June 18, 2001; Application Receipt Date: July 18, 2001
The National Institute of Mental Health (NIMH) invites applications from intramural and extramural scientists for the "NIMH Research Career Award for Transition to Independence" program. This initiative is designed to attract and train outstanding physician scientists and senior postdoctoral investigators (with at least 2-3 years of postgraduate research experience), who wish to further their basic or clinical career development experience by initially training within the NIMH Division of Intramural Research Programs (intramural phase), and then transitioning to an independent research program at a domestic U.S. extramural institution (extramural phase).
- METALS IN MEDICINE (PA-01-071)
National Institute of General Medical Sciences
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
Office of Dietary Supplements, Office of the Director, NIH
The objective of this program announcement is to encourage research that bridges the areas of inorganic chemistry and medicine. The mechanisms by which organisms control transition metal ions and the roles of these metals in cellular regulation and cell-cell signaling are of primary interest. The interactions of synthetic inorganic complexes with living systems and their components are a second area of interest.
- PHASED APPLICATION AWARDS IN CANCER PROGNOSIS AND PREDICTION (NCI) (PAR-01-061)
Letter of Intent Date: May 9, 2001, November 6, 2001, May 2, 2002, and November 7, 2002
Application Receipt Date: June 13, 2001, December 11, 2001, June 11, 2002, and December 11, 2002
The Cancer Diagnosis Program of the National Cancer Institute invites applications for research projects to evaluate the utility and pilot the application of new strategies for determining prognosis or predicting response to therapy. This will provide tools to improve clinical decision-making in the care of cancer patients. This Program Announcement (PAR) provides support for a first phase (R21) for technical development and a second phase (R33) for application and evaluation of clinical utility.
Small businesses are encouraged to consider a parallel program announcement (http://grants.nih.gov/grants/guide/pa-files/PAR-01-062.html) of identical scientific scope that utilizes the SBIR and STTR mechanisms with accelerated transitional review, as well as cost and duration requirements, comparable to the Phased Application Awards
- NCI TRANSITION CAREER DEVELOPMENT AWARD FOR UNDERREPRESENTED MINORITIES (PAR-01-074)
The NCI invites transition career development award applications from recipients of the NCI Mentored Career Development Award for Underrepresented Minorities or from underrepresented minority individuals who are advanced postdoctoral and/or newly independent research scientists who have been in an independent position for less than two years at the time of the application. The NCI Transition Career Development Award for Underrepresented Minorities (K22) will provide salary up to $75,000 annually plus fringe benefits.
Other Government Agenices
- Fiscal Year 2001 (FY01) Department of Defense (DOD) Peer Reviewed Medical Research Program (PRMRP) (SOL CBD-PRM-0305)
Deadline: 4/25/2001; 5/16/2001
The Defense Appropriations Act of 2001 (Public Law 106-295) provides $50 million to fund peer-reviewed research pertinent to the health of our military forces in 31 topic areas. As the executive agent for this program, the United States Army Medical Research and Materiel Command (USAMRMC) requests intramural and extramural research proposals relevant to military health on the a number of topics, including Acute Lung Injury Research; CAT Scan Technology for Lung Cancer; Digital Mammography Imaging; Health Care Informatics; Human Imaging Institute/Magnetoencephalography Laboratory; Medical Surgery Technology; Microsurgery and Robotic Surgery Research; Molecular Biology for Cancer Research; Remote Emergency Medicine Ultrasound.
- Department of Defense Breast Cancer Research Program for Fiscal Year 2001, FY 01 BCRP Program Announcement II
This announcement calls for proposals in the following mechanisms: Idea Awards, Clinical Bridge Awards, Predoctoral Traineeship Awards, Postdoctoral Traineeship Awards, Career Development Awards, Undergraduate Summer Training Program Awards, Historically Black Colleges and Universities/Minority Institutions Partnership Training Awards, Innovator Awards (new this year).
- Department of Defense Ovarian Cancer Research Program for Fiscal Year 2001 (SOL CBD-OCRP-0326)
The Fiscal Year 2001 (FY01) Defense Appropriations Act provides $12 million to the Department of Defense Ovarian Cancer Research Program (OCRP). This program has been administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) through its Office of Congressionally Directed Medical Research Programs (CDMRP). The OCRP is encouraging research focused on epithelial ovarian carcinoma and/or primary peritoneal carcinoma. In addition, the following research areas are being emphasized: (1) etiology, (2) prevention, (3) early detection/diagnosis, (4) preclinical therapeutics, (5) quality of life, and (6) behavioral studies.
- Association for the Cure of Cancer of the Prostate (CaP CURE)
Research Award: Applications will be accepted August 13, 2001 through October 12, 2001.
Applications may be postmarked no later than October 12, 2001.
Young Investigator Award Applications Deadline is June 1, 2001.
CaP CURE will continue to fund outstanding and novel basic science that we believe is the cornerstone in the discovery of a cure for prostate cancer.
- RSNA World Wide Web-Based Educational Program
The purpose is too develop educational materials specifically for wide spread distribution through the World Wide Web. There is up to $75,000 for a one-year program with the possibility of a second year of support at the level of up to $75,000. This program is open to anyone in the radiological sciences throughout the world.
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (email@example.com).
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507